Your browser doesn't support javascript.
loading
BCMA-Targeted CAR T-cell Therapy plus Radiotherapy for the Treatment of Refractory Myeloma Reveals Potential Synergy.
Smith, Eric L; Mailankody, Sham; Staehr, Mette; Wang, Xiuyan; Senechal, Brigitte; Purdon, Terence J; Daniyan, Anthony F; Geyer, Mark B; Goldberg, Aaron D; Mead, Elena; Santomasso, Bianca D; Landa, Jonathan; Rimner, Andreas; Riviere, Isabelle; Landgren, Ola; Brentjens, Renier J.
Affiliation
  • Smith EL; Cellular Therapeutics Center, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. smithe3@mskcc.org brentjer@mskcc.org.
  • Mailankody S; Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Staehr M; Cellular Therapeutics Center, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Wang X; Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Senechal B; Cellular Therapeutics Center, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Purdon TJ; Cell Therapy and Cell Engineering Facility, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Daniyan AF; Cell Therapy and Cell Engineering Facility, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Geyer MB; Cellular Therapeutics Center, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Goldberg AD; Cellular Therapeutics Center, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Mead E; Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Santomasso BD; Cellular Therapeutics Center, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Landa J; Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Rimner A; Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Riviere I; Cellular Therapeutics Center, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Landgren O; Department of Anesthesiology and Critical Care Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Brentjens RJ; Cellular Therapeutics Center, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
Cancer Immunol Res ; 7(7): 1047-1053, 2019 07.
Article de En | MEDLINE | ID: mdl-31113804
Sujet(s)
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Radiothérapie / Récepteurs aux antigènes des cellules T / Lymphocytes T / Immunothérapie adoptive / Résistance aux médicaments antinéoplasiques / Antigène de maturation des cellules B / Myélome multiple Limites: Female / Humans / Middle aged Langue: En Journal: Cancer Immunol Res Année: 2019 Type de document: Article Pays de publication: États-Unis d'Amérique
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Radiothérapie / Récepteurs aux antigènes des cellules T / Lymphocytes T / Immunothérapie adoptive / Résistance aux médicaments antinéoplasiques / Antigène de maturation des cellules B / Myélome multiple Limites: Female / Humans / Middle aged Langue: En Journal: Cancer Immunol Res Année: 2019 Type de document: Article Pays de publication: États-Unis d'Amérique